- Home
- GOSS vs MUA Comparison
GOSS vs MUA Comparison
Compare GOSS & MUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- MUA
- Stock Information
- Founded
- GOSS 2015
- MUA 1993
- Country
- GOSS United States
- MUA United States
- Employees
- GOSS N/A
- MUA N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- MUA Investment Bankers/Brokers/Service
- Sector
- GOSS Health Care
- MUA Finance
- Exchange
- GOSS Nasdaq
- MUA Nasdaq
- Market Cap
- GOSS 347.8M
- MUA 407.1M
- IPO Year
- GOSS 2019
- MUA N/A
- Fundamental
- Price
- GOSS $1.96
- MUA $10.56
- Analyst Decision
- GOSS Strong Buy
- MUA
- Analyst Count
- GOSS 4
- MUA 0
- Target Price
- GOSS $8.50
- MUA N/A
- AVG Volume (30 Days)
- GOSS 3.2M
- MUA 92.6K
- Earning Date
- GOSS 08-05-2025
- MUA 01-01-0001
- Dividend Yield
- GOSS N/A
- MUA 4.84%
- EPS Growth
- GOSS N/A
- MUA N/A
- EPS
- GOSS N/A
- MUA N/A
- Revenue
- GOSS $40,237,000.00
- MUA N/A
- Revenue This Year
- GOSS N/A
- MUA N/A
- Revenue Next Year
- GOSS $63.97
- MUA N/A
- P/E Ratio
- GOSS N/A
- MUA N/A
- Revenue Growth
- GOSS N/A
- MUA N/A
- 52 Week Low
- GOSS $0.66
- MUA $8.61
- 52 Week High
- GOSS $2.23
- MUA $11.43
- Technical
- Relative Strength Index (RSI)
- GOSS 58.35
- MUA 66.16
- Support Level
- GOSS $1.67
- MUA $10.02
- Resistance Level
- GOSS $2.00
- MUA $10.75
- Average True Range (ATR)
- GOSS 0.17
- MUA 0.11
- MACD
- GOSS -0.02
- MUA 0.03
- Stochastic Oscillator
- GOSS 52.21
- MUA 64.91
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About MUA Blackrock MuniAssets Fund Inc
Blackrock Muniassets Fund Inc is a closed-end fund. Its objective is to provide high current income exempt from U.S. federal income taxes by investing in a portfolio of medium- to lower-grade or unrated municipal obligations. The Fund invests more of its total assets in municipal bonds.